Dean Kim, MD
Transplant Surgery · Detroit, MINPI 1215090832
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,030 of the $13,865 with a category attached, or 72.3%. Merck accounts for 98.1% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $8,422, more than ten times the $145 reported in 2023.
Across 15 payments — averaging $924.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$14K
- Intuitive Surgical$145
- Vertex$125
Across 338 payments — averaging $3187.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1.1M
- Novartis Pharma AG$3K
- Eli Lilly$286
What the payments were for
- Speaking & faculty fees$10,03072%
- Travel & lodging$3,41525%
- Food & beverage$4193%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 11 | $13,595 |
| Intuitive Surgical | 3 | $145 |
| Vertex | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few transplant surgery providers in Michiganto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $33 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Detroit
- Atsushi YoshidaDetroit$219K
- Adhnan MohamedDetroit$14K
- Ahmed NassarDetroit$6K
- Shunji NagaiDetroit$4K
- Abbas Al-KurdDetroit$4K
- Luckshi RajendranDetroit$2K
- Shakir HusseinDetroit$953
- Kazuhiro TakahashiDetroit$72
- Kyle SheetzAnn Arbor$2K
- Ben BiesterveldAnn Arbor$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.